Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes

Diabetes

Volumn 46, Issue 1, 1997, Pages 138-142

  Morishita, Ryuichi ^a   Nakamura, Shigefumi ^a   Nakamura, Yoshio ^a   Aoki, Motokuni ^a   Moriguchi, Atsushi ^a   Kida, Iwao ^a   Yo, Yoshikage ^a   Matsumoto, Kunio ^a   Nakamura, Toshikazu ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a,b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DIABETES MELLITUS; ENDOTHELIUM INJURY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0031013709     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.1.138     Document Type: Article

References (43)

1. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ: Hyperpolarization and relaxation of atrial smooth muscle caused by nitric oxide derived from the endothelium. Nature 346:69-71, 1990
2. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H: Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of "Vascular natriuretic peptide system." J Clin Invest 90:1145-1149, 1992
3. Itoh H, Pratt RE, Dzau VJ: Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 86:1690-1697, 1990
4. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 241:2035-2038, 1979
5. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
6. Tesfamariam B, Brown ML, Cohen RA: Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648, 1991
7. Hsueh WA, Anderson PW: Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus (Clinical Conference). Hypertension 20:253-263, 1992
8. Dzau VJ, Gibbons GH: Endothelium and growth factors in vascular remodeling of hypertension. Hypertension 18 (Suppl. III):III-115-III-121, 1991
9. Dzau VJ: The role of mechanical and humoral factors in growth regulation of vascular smooth muscle cells and cardiac myocytes. Curr Opin Nephrol Hypertens 2:27-32, 1993
10. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T: A vascular modulator, hepatocyte growth factor, is associated with systolic blood pressure. Hypertension 28:409-413, 1996
11. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, Matsumoto K, Nakamura T, Ogihara T: Hepatocyte growth factor (HGF) is a novel member of endothelium-specific growth factors: additive stimulatory effect of HGF with basic fibroblast growth factor, but not vascular endothelial growth factor. J Hypertens 14:1067-1072, 1996
12. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, Nakamura T, Ogihara T: Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 215:483-488, 1995
13. Matsumoto K, Tashiro K, Tajima H, Okazaki H, Nakamura T: Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β and glucocorticoids. J Biol Chem 267:24917-24920, 1992
14. Okajima A, Miyazawa K, Kitamura N: Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene. Eur J Biochem 213:113-119, 1993
15. Liu Y, Michalopoulos G, Zarnegar R: Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 269:4152-4160, 1994
16. Gohda E, Matsunaga T, Kataoka H, Yamamoto I: TGF-β is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int Rep 16:917-926, 1992
17. Nakamura Y, Morishita R, Higaki J, Kida I, Hayashi S, Aoki M, Yo Y, Moriguchi A, Matsumoto K, Nakamura T, Ogihara T: Differential regulation of local hepatocyte growth factor, endothelium-specific growth factor, production in vascular cells (Abstract). J Hypertens. In press
18. Wertheimer SJ, Myers CL, Wallace RW, Parks TP: Intercellular adhesion molecule-1 gene expression in human endothelial cells. J Biol Chem 267:12030-12035, 1992
19. Bonin PD, Leadley RJ, Erickson LA: Growth factor-induced modulation of endothelial-1 binding to human smooth muscle cells. J Cardiovasc Pharmacol 22:S125-S127, 1993
20. +: the implication of a protective role of αB-crystallin accumulation in reactive glia. Brain Res 673:47-52, 1995
21. Shirahata S, Watanabe J, Teruya K, Yano T, Osada K, Ohashi H, Tachibana H, Kim EH, Murakami H: E1A and ras oncogenes synergistically enhance recombinant protein production under control of the cytomegalovirus promoter in BHK-21 cells. Biosci Biotech Biochem 59:345-347, 1995
22. Ishiyama M, Shiga M, Sasamoto K, Mizoguchi M, He P: A new sulfonated tertazolium salt that produces a highly water-soluble formazan dye. Chem Pharm Bull 41:1118-1122, 1993
23. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
24. Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, Nakamura T: Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 16:105-114, 1995
25. Nakamura T, Hagiya M, Nishizawa T, Seki T, Shimonishi M, Sugiura A, Tashiro K, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443, 1989
26. Seki T, Ihara I, Sugiyama M, Nishizawa T, Asami O, Hagiya M, Nakamura T, Shimizu S: Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocytes. Biochem Biophys Res Commun 172:321-327, 1990
27. Graier WF, Wascher TC, Lackner L, Toplak H, Krejs GJ, Kukovetz WR: Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes 42:1497-1505, 1993
28. Matsumoto K, Nakamura T: Roles of HGF as a pleiotropic factor in organ regeneration. In Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and C-Met Receptor. Goldberg ID, Rosen EM, Eds. Basel, Birkhauser Verlag, 1993, p. 225-249
29. Nakamura T: Structure and function of hepatocyte growth factor. Prog Growth Factor Res 3:67-86, 1991
30. Boros P, Miller CM: Hepatocyte growth factor: a multifunctional cytokine. Lancet 345:293-295, 1995
31. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessi A, Waldhausl W: High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44:1323-1327, 1995
32. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536-542, 1994
33. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42:647-656, 1992
34. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int 41:107-114, 1992
35. Rakugi H, Gibbons GH, Wang D, Billingham M, Vershave K, Feruson J, Angelini P, Hogan P, Massumi A, Buja LM, Blubb F, McAllister H, Willerson JT, Dzau VJ: Expression of transforming growth factor beta 1 in human atherectomy specimens from primary and restenotic coronary artery lesions (Abstract). J Am Coll Cardiol 19:329A, 1992
36. Nikol S, Isner M, Picketing JG, Kearney M, Leclerc G, Weir L: Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest 90:1582-1592, 1992
37. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
38. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
39. Hsueh WA, Anderson PW: Systemic hypertension and the renin-angiotensin system in diabetic vascular complications. Am J Cardiol 72:14H-21H, 1993
40. Williams B: Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C. J Hypertens 13:477-486, 1995
41. Lee TS, Saltsman KA, Ohashi H, King GL: Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86:5141-5145, 1989
42. Williams B, Schrier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41:1464-1472, 1992
43. Graier WF, Grubenthal I, Dittrich P, Wascher TC, Kostner GM: Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur J Pharmacol 294:221-229, 1995